Breast Cancer Awareness Month 2026: The Numbers Behind the Ribbon, in Georgia, Nationwide, and Around the World

In October, a pink ribbon can bring a family story to mind: a mother who faced treatment, an aunt who died too soon, a sister who is now thriving, or a friend waiting for test results.

Behind every statistic is a person whose life reaches far beyond a medical chart. The numbers below help us see the size of the challenge, the progress that’s been made, and where families still need better access to timely, respectful care.

Why These Numbers Matter to Families

Statistics describe populations and trends. They don’t predict what will happen to one individual.

A projected number of diagnoses doesn’t tell us who will become sick. An age-adjusted mortality rate doesn’t measure one person’s risk. Instead, these figures show where prevention, screening, diagnosis, treatment, follow-up, and support systems are working, and where they need improvement.

When we read the numbers this way, awareness becomes more than a ribbon. It becomes a shared commitment to making care easier to reach and harder to delay.

Georgia: A Local Picture of Breast Cancer

The American Cancer Society’s Cancer Facts & Figures 2026 projects 10,440 new breast cancer cases and 1,430 breast cancer deaths among women in Georgia in 2026 (American Cancer Society [ACS], 2026). These are projections, not final counts.

Georgia’s broader cancer burden is also substantial. The Georgia Department of Public Health’s Comprehensive Cancer Control Plan 2024–2029 reports that cancer was the state’s second leading cause of death in 2023, accounting for one in five deaths. The plan reports 18,435 cancer deaths among Georgians that year (Georgia Department of Public Health [GDPH], n.d.).

The data also show a serious racial disparity. From 2017 through 2021, non-Hispanic Black women in Georgia were 38% more likely to die of breast cancer than non-Hispanic White women. The age-adjusted mortality rates were 26.8 deaths per 100,000 Black women and 19.3 per 100,000 White women (GDPH, n.d.).

More recent data tell a similar story while covering a different period. The National Cancer Institute’s State Cancer Profiles reports that, from 2019 through 2023, breast cancer mortality among non-Hispanic Black females in Georgia was 26.5 age-adjusted deaths per 100,000, averaging about 507 deaths per year (National Cancer Institute State Cancer Profiles [NCI SCP], 2026). This is a five-year population measure, not a real-time 2026 rate, and it isn’t an individual risk prediction.

Screening data provide additional context. In 2024, 78.8% of Georgia women ages 50–74 reported having a mammogram within the past two years, compared with 78.5% nationally. Among women ages 40 and older, the Georgia figure was 70.9%, compared with 72.2% nationally (NCI SCP, 2026). These screening and mortality figures cover different periods and shouldn’t be treated as a causal comparison.

The United States: Progress Alongside Persistent Gaps

Nationally, ACS projects 321,910 new invasive breast cancer cases, 60,730 cases of ductal carcinoma in situ, and 42,140 breast cancer deaths among women in 2026 (ACS, 2026).

There has been meaningful progress. Breast cancer death rates have declined by about 44% since 1989, reflecting advances in detection and treatment (ACS, 2026). That progress matters. It also reminds us that public-health action can save lives.

Yet access remains uneven. A 2026 review by Rademacher, Wall, and Huynh found that the percentage of women age 40 and older reporting a mammogram within the past year varied by racial and ethnic group:

• American Indian/Alaska Native women: 31%
• Asian American women: 44%
• Hispanic/Latina women: 44%

The same review found that rural women had lower odds of ever having a mammogram (odds ratio 0.74) and lower odds of being current with screening (odds ratio 0.59). Rural patients also had higher odds of a late-stage diagnosis (Rademacher et al., 2026).

Around the World: A Shared Health Challenge

The World Health Organization and International Agency for Research on Cancer’s GLOBOCAN 2022 estimates record 2,296,840 new breast cancer cases and 666,103 breast cancer deaths among women worldwide in 2022 (World Health Organization [WHO], n.d.).

Breast cancer was the most commonly diagnosed cancer among women in 157 of 185 countries. About 80% of cases occur in women with no identifiable risk factor beyond sex and age. Breast cancer also occurs in men, who account for approximately 0.5% to 1% of cases (WHO, n.d.).

An IARC analysis published in 2025 estimates that about one in 20 women will be diagnosed with breast cancer during her lifetime, while about one in 70 will die from it. The outlook varies substantially by region. If current rates continue, annual cases could reach approximately 3.2 million, with about 1.1 million deaths, by 2050 (International Agency for Research on Cancer [IARC], 2025).

The WHO Global Breast Cancer Initiative sets a measurable goal:

“Reduce global breast cancer mortality by 2.5% per year between 2020 and 2040.” (WHO, n.d.)

That goal focuses on three connected steps: health promotion and early detection, timely diagnosis, and comprehensive treatment.

Veterans and Women Veterans

Women veterans are a growing and important part of the breast cancer conversation. The U.S. Department of Veterans Affairs reports approximately 2.1 million women veterans in the United States. They’re the fastest-growing group within the veteran population and are projected to represent roughly 17% to 18% of all veterans by 2040–2043. In 2023, about 930,000 women veterans were enrolled in VA health care, and approximately 650,000 sought VA medical care (U.S. Department of Veterans Affairs [VA], 2025).

Breast cancer is the most common cancer diagnosed among women veterans receiving care through VA. About 87% of eligible women veterans receive mammograms at VA, but barriers can include wait times, travel distance, limited women’s health providers, and limited local mammography access (VA Health Services Research & Development [VA HSR&D], 2025).

VA News reported that approximately 1,200 veterans in VA care are diagnosed with breast cancer each year (VA, 2024). VA HSR&D data from 2021–2024 identified 7,187 incident breast and gynecologic cancers among living veterans. About 78% were breast cancers. The average age at breast cancer diagnosis was 59, and women veterans were diagnosed at younger ages than the general U.S. population (VA HSR&D, 2025).

Georgia’s Department of Veterans Service reports that the state is home to roughly 650,739 veterans, including nearly 93,000 women veterans (Georgia Department of Veterans Service [GDVS], 2025).

Why Screening Alone Isn’t Enough

Screening can find cancer earlier, but it’s only one point on the care continuum.

Rademacher et al. (2026) found that higher screening rates among Black women haven’t translated into better outcomes. Longer follow-up times, delays in diagnosis and treatment, and higher mortality remain concerns. The authors call for action across the entire continuum of care, not screening alone, and reference the recommendation that Black women receive a race-inclusive breast cancer risk assessment by age 25.

Practical barriers matter, too. Appointment nonadherence was 25.1% among patients with childcare barriers, compared with 15.2% among those without childcare barriers (Rademacher et al., 2026).

Mobile mammography can expand access, but follow-up must be built into the design. One New York City program served 32,350 women, offered additional testing for more than 5,000 abnormal results, and diagnosed 68 breast cancers. Rademacher et al. caution that mobile units may have higher recall rates, while patients with recalls may be less likely to return for additional imaging.

What Works

The evidence also offers reasons for hope.

In one randomized trial among Hispanic migrant women, vouchers increased screening from 17.5% to 87%. Eliminating cost sharing increased screening, especially among younger women. A DVD intervention had an odds ratio of 1.84 for screening; adding patient navigation increased the odds ratio to 5.69 (Rademacher et al., 2026).

In plain language, these findings suggest that people are more likely to complete screening when systems reduce cost, explain the process, offer reminders, and provide help with transportation and follow-up. Navigation can be especially effective in low-resource settings, although its benefits may take three months or longer to appear.

What You Can Do

Perhaps start with one conversation:

• Know your personal risk and family history.
• Ask a clinician when screening should begin and how often it should occur.
• Ask whether a race-inclusive or other formal risk assessment is appropriate.
• Follow up promptly after an abnormal screening result.
• Ask whether patient navigation is available.
• Ask about transportation, childcare, and cost assistance.
• Request language interpretation or translated materials when needed.

Useful questions include:

• “What screening schedule fits my age and risk?”
• “Do I need a risk assessment or genetic counseling?”
• “What happens after an abnormal mammogram?”
• “Who can help me arrange transportation or childcare?”
• “How will I receive my results, and when should I follow up?”

Important Limitations

These figures don’t all measure the same thing. Projections are estimates. Reporting systems have delays. Age-adjusted rates help compare populations with different age structures, but they don’t predict an individual’s outcome. Odds ratios describe group-level associations; they don’t determine what will happen to one person. Screening percentages and mortality rates also cover different periods.

Takeaway

The numbers show both progress and unfinished work. Breast cancer death rates have fallen nationally, yet racial, geographic, financial, and logistical barriers continue to shape who gets screened, diagnosed, treated, and supported.

This Breast Cancer Awareness Month, we can learn from reliable data, share accurate information, and gently encourage someone we care about to schedule recommended screening or follow up on an unanswered medical question. Small actions can help move people from awareness to timely care.

Medical Disclaimer

This article is for general education and isn’t medical advice. Screening recommendations depend on personal history, age, risk factors, and current clinical guidance. Please speak with a qualified healthcare professional about your individual care.

References

American Cancer Society. (2026). Cancer facts & figures 2026. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2026-cancer-facts-figures.html

American Cancer Society. (2026). Estimated number of new cancer cases and deaths by state, 2026. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2026/mr4-cases-by-state-2026-branded.pdf

Georgia Department of Public Health. (n.d.). Comprehensive cancer control plan 2024–2029. https://www.georgiacancer.org/wp-content/uploads/2025/04/2024-2029-Comprehensive-Cancer-Control-Plan.pdf

Georgia Department of Veterans Service. (2025). Veteran population estimates. https://veterans.georgia.gov/rvtf-women-veterans

International Agency for Research on Cancer. (2025). Breast cancer cases and deaths are projected to rise globally [Press release]. https://www.nature.com/articles/s41591-025-03502-3

National Cancer Institute State Cancer Profiles. (2026). Death rates: Breast cancer, Georgia [Data table]. https://statecancerprofiles.cancer.gov/

National Cancer Institute State Cancer Profiles. (2026). Quick profiles: Georgia. https://statecancerprofiles.cancer.gov/quick-profiles/index.php?statename=georgia

Rademacher, N., Wall, C. S., & Huynh, V. D. (2026). Barriers to solutions: A framework guided review of social determinants of breast cancer screening and interventions designed to address them. Current Breast Cancer Reports, 18, 50. https://doi.org/10.1007/s12609-026-00672-y

U.S. Department of Veterans Affairs. (2024). Breast cancer screenings could save your life. VA News. https://news.va.gov/

U.S. Department of Veterans Affairs. (2025). Facts and statistics: Women veterans health care. https://www.womenshealth.va.gov/materials-and-resources/facts-and-statistics.asp

U.S. Department of Veterans Affairs, Health Services Research & Development. (2025). Women veterans’ cancer care research. https://www.research.va.gov/topics/womens_health.cfm

World Health Organization. (n.d.). Breast cancer [Fact sheet]. https://www.who.int/news-room/fact-sheets/detail/breast-cancer